Lead compounds and key residues of ribosomal protein S1 in drug-resistant Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lead compounds and key residues of ribosomal protein S1 in drug-resistant Mycobacterium tuberculosis

Published:2019-02 Issue: Volume:82 Page:58-67
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Zhi Yunbao,Dai Yazhuang,Yang Juanjuan,Tan Shuhua,Lin Donghai,Lin Kejiang

Funder

National Natural Science Foundation of China, China

National Key Research and Development Program of China, China

China Pharmaceutical University Initiative Program, China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference33 articles.

1. Global Tuberculosis Report 2016;Organization,2016

2. The action of antituberculosis drugs in short-course chemotherapy;Mitchison;Tubercle,1985

3. Identification and validation of novel drug targets in Mycobacterium tuberculosis;Singh;Drug Discov. Today,2017

4. The future for early-stage tuberculosis drug discovery;Zuniga;Future Microbiol.,2015

5. Inflammation and tuberculosis: host-directed therapies;Zumla;J. Intern. Med.,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribosomal protein L17 functions as an antimicrobial protein in amphioxus;Fish & Shellfish Immunology;2024-09

2. In silico identification of phytochemical inhibitors for multidrug-resistant tuberculosis based on novel pharmacophore generation and molecular dynamics simulation studies;BMC Chemistry;2024-04-18

3. Synthesis, kinetics, structure-activity relationship and in silico ADME studies of new diazenyl azo-phenol derivatives against urease, SARS-CoV-2 main protease (Mpro) and ribosomal protein S1 (RpsA) of Mycobacterium tuberculosis;Journal of Molecular Structure;2022-04

4. In Silico Drug Designing for ala438 Deleted Ribosomal Protein S1 (RpsA) on the Basis of the Active Compound Zrl15;ACS Omega;2021-12-29

5. Exploring Amyloidogenicity of Peptides From Ribosomal S1 Protein to Develop Novel AMPs;Frontiers in Molecular Biosciences;2021-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3